Massive study aims to unlock mysteries of rare blood vessel disease
NCT ID NCT02257866
First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 14 times
Summary
This study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to find better ways to diagnose and predict relapses, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 4,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2014
- Expected to finish
-
Jan 2050
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
idiopathic systemic vasculitis in children and adults
- Ages
-
3 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA SUBJECTS WITH VASCULITIS: Subjects with known or suspected diagnosis of idiopathic systemic vasculitis will be evaluated either at the outpatient or inpatient unit of the Clinical Center as indicated. * Subjects who fulfill modified versions of the 1990 American College of Rheumatology (ACR) Classification Criteria for GPA and PAN * Subjects who fulfill the 1990 ACR Classification Criteria for EGPA, GCA, and TAK * Subjects who fulfill the 2012 Chapel Hill Nomenclature definition for MPA * Subjects with other suspected systemic or single-organ vasculitides EXCLUSION CRITERIA FOR SUBJECTS WITH VASCULITIS: * Subjects \< 3 years of age * Active malignancy, infection, or any medical condition that in the opinion of the investigator would warrant exclusion * Inability to provide consent, or in the case of minors, assent * Subjects with bleeding diathesis or on anticoagulant medications (e.g. coumadin, heparin, clopidogrel but not including aspirin or NSAIDs) are excluded from participation in nasal brushing or biopsy studies Reason for early termination -Withdrawal of consent INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: Healthy volunteers will be recruited to serve as controls for studies on peripheral blood samples. -Volunteers able to provide consent, or in the case of minors, assent EXCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: * Volunteers \< 3 years of age risk * Diagnosis of vasculitis or other autoimmune/autoinflammatory disease, including systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis, mixed connective tissue disease or any overlap autoimmune syndrome * Active malignancy, infection, or any medical condition that in the opinion of the investigator would warrant exclusion * Pregnant (by history of last menstrual period) or breast-feeding subjects * Subjects with bleeding diathesis or taking anticoagulant medications (e.g. coumadin, heparin, clopidogrel but not including aspirin or NSAIDs) are excluded from participating in nasal brushing studies
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA associated vasculitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine test expose hidden immune weakness?
- Could a blood pressure pill shield blood vessels from heart attacks?
- A blood clue to a rare vessel disease?
- Immune clues in the blood may foretell heart trouble
- Can a new drug tame vasculitis with fewer side effects?
- Engineered immune cells take aim at autoimmune kidney diseases